SecBot SecBot
DEFA14A ·Filed Apr 6, 2026

TMCI

TREACE MEDICAL CONCEPTS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed7mo ago SEC0001630627-26-000006
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine regulatory filing with no immediate implications for trading. No action is required.

DirectionNeutral
Confidencelow
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$1.44
T+0 close · Apr 6, 2026 · via day close
Latest settled
+193.75%
T+60 · $4.23
Vs SPY
+180.28%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 6 $1.44entry
  2. T+1 · 8mo ago −6.94%α −7.01% · $1.34
  3. T+5 · 7mo ago +39.58%α +35.45% · $2.01
  4. T+20 · 7mo ago +27.08%α +18.10% · $1.83
  5. T+60 · 5mo ago +193.75%α +180.28% · $4.23
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Treace Medical Concepts, Inc. filed a definitive proxy statement (DEFA14A) for its 2026 annual meeting. The filing is routine and does not contain any new material financial information or significant corporate actions.

Key Financial Metrics

Vote
director election
Meeting
2026-04-06

Key Facts

  • The filing is a routine proxy statement (DEFA14A) for the 2026 annual meeting.
  • No material financial data, new agreements, or significant corporate actions are disclosed in the filing.
  • The filing type is standard and does not indicate any immediate changes in company operations or strategy.

Financial Impact

No material financial impact disclosed

Risk Factors

  • The filing is routine and does not contain any material information that would affect investment decisions.
  • The lack of material information means there is no immediate risk or opportunity.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001630627-26-000006
Document: 0001630627-26-000006-index-headers.html0001630627-26-000006
Document: 0001630627-26-000006-index.html0001630627-26-000006
Document: 0001630627-26-000006.txt0001630627-26-000006

Track record

11 reports on TMCI

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +12.39% at T+60 after the Jul 13, 2026 report. 2 of 3 went positive at some point.

Filters
  1. Nov 16, 20261d ago SC 13G Neutral 4/10 Entry $4.42 to $4.44 Now $4.44 +0.45% ▲ +0.45% +1.47% vs SPY
  2. Nov 16, 20261d ago SC 13G/A Bearish 4/10 Entry $4.42 to $4.44 Now $4.44 −0.45% ▼ −0.45% −1.47% vs SPY
  3. Nov 12, 20266d ago Court Ruling Neutral 4/10 Entry $5.27 to $4.42 Now $4.44 −15.75% ▼ −16.13% −14.22% vs SPY
  4. Nov 6, 202611d ago 8-K Neutral 4/10 Entry $4.03 to $4.78 Now $4.44 +10.17% ▲ +18.61% +16.24% vs SPY
  5. Sep 17, 20268w ago Press Release Neutral 4/10 Entry $4.49 to $4.48 Now $4.44 −1.11% ▼ −0.22% −1.77% vs SPY
  6. Aug 7, 202614w ago 8-K Mixed 6/10 Entry $4.76 to $4.67 Now $4.44 −6.72% ▼ −1.89% −1.86% vs SPY
  7. Jul 13, 202618w ago Court Ruling Bearish 5/10 Entry $4.44 to $4.40 Now $4.44 −0.00% ▲ +0.90% +1.30% vs SPY
  8. May 8, 202627w ago Press Release Bearish 7/10 Entry $2.01 to $1.94 Now $4.44 −120.90% ▲ +3.48% +3.71% vs SPY
  9. Apr 24, 202629w ago Press Release Neutral 1/10 Entry $1.98 to $1.92 Now $4.44 +124.24% ▼ −3.03% −3.19% vs SPY
  10. Apr 9, 202631w ago 8-K Mixed 6/10 Entry $1.53 to $1.81 Now $4.44 +190.20% ▲ +18.30% +18.36% vs SPY
Showing 10 of 11

US Market Status

Market Closed · Opens Thu (11h 35m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 6, 2026